BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 22134517)

  • 1. Improving the therapeutic ratio by using proton therapy in patients with stage I or II seminoma.
    Hoppe BS; Mamalui-Hunter M; Mendenhall NP; Li Z; Indelicato DJ
    Am J Clin Oncol; 2013 Feb; 36(1):31-7. PubMed ID: 22134517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of three-dimensional (3D) conformal proton radiotherapy (RT), 3D conformal photon RT, and intensity-modulated RT for retroperitoneal and intra-abdominal sarcomas.
    Swanson EL; Indelicato DJ; Louis D; Flampouri S; Li Z; Morris CG; Paryani N; Slopsema R
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1549-57. PubMed ID: 22270176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protons offer reduced normal-tissue exposure for patients receiving postoperative radiotherapy for resected pancreatic head cancer.
    Nichols RC; Huh SN; Prado KL; Yi BY; Sharma NK; Ho MW; Hoppe BS; Mendenhall NP; Li Z; Regine WF
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):158-63. PubMed ID: 22245197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consolidative involved-node proton therapy for Stage IA-IIIB mediastinal Hodgkin lymphoma: preliminary dosimetric outcomes from a Phase II study.
    Hoppe BS; Flampouri S; Su Z; Morris CG; Latif N; Dang NH; Lynch J; Li Z; Mendenhall NP
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):260-7. PubMed ID: 22014950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can proton therapy improve the therapeutic ratio in breast cancer patients at risk for nodal disease?
    Xu N; Ho MW; Li Z; Morris CG; Mendenhall NP
    Am J Clin Oncol; 2014 Dec; 37(6):568-74. PubMed ID: 23466577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant radiation therapy for early stage seminoma: proton versus photon planning comparison and modeling of second cancer risk.
    Efstathiou JA; Paly JJ; Lu HM; Athar BS; Moteabbed M; Niemierko A; Adams JA; Bekelman JE; Shipley WU; Zietman AL; Paganetti H
    Radiother Oncol; 2012 Apr; 103(1):12-7. PubMed ID: 22391053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective dose reduction to cardiac structures using protons compared with 3DCRT and IMRT in mediastinal Hodgkin lymphoma.
    Hoppe BS; Flampouri S; Su Z; Latif N; Dang NH; Lynch J; Joyce M; Sandler E; Li Z; Mendenhall NP
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):449-55. PubMed ID: 22386373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicted rates of secondary malignancies from proton versus photon radiation therapy for stage I seminoma.
    Simone CB; Kramer K; O'Meara WP; Bekelman JE; Belard A; McDonough J; O'Connell J
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):242-9. PubMed ID: 21236595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosimetry and radiobiologic model comparison of IMRT and 3D conformal radiotherapy in treatment of carcinoma of the prostate.
    Luxton G; Hancock SL; Boyer AL
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):267-84. PubMed ID: 15093924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensity-modulated radiotherapy improves lymph node coverage and dose to critical structures compared with three-dimensional conformal radiation therapy in clinically localized prostate cancer.
    Wang-Chesebro A; Xia P; Coleman J; Akazawa C; Roach M
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):654-62. PubMed ID: 17011444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose comparison of robustly optimized intensity modulated proton therapy (IMPT) vs IMRT and VMAT photon plans for testicular seminoma.
    Rønde HS; Kronborg C; Høyer M; Hansen J; Bak ME; Agergaard SN; Als AB; Agerbæk M; Lauritsen J; Meidahl Petersen P; Dysager L; Kallehauge JF
    Acta Oncol; 2023 Oct; 62(10):1222-1229. PubMed ID: 37683054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosimetric comparison of combined intensity-modulated radiotherapy (IMRT) and proton therapy versus IMRT alone for pelvic and para-aortic radiotherapy in gynecologic malignancies.
    Milby AB; Both S; Ingram M; Lin LL
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):e477-84. PubMed ID: 22177626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosimetric evaluation of conventional radiotherapy, 3-D conformal radiotherapy and direct machine parameter optimisation intensity-modulated radiotherapy for breast cancer after conservative surgery.
    Zhang F; Zheng M
    J Med Imaging Radiat Oncol; 2011 Dec; 55(6):595-602. PubMed ID: 22141607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosimetric comparison of three-dimensional conformal proton radiotherapy, intensity-modulated proton therapy, and intensity-modulated radiotherapy for treatment of pediatric craniopharyngiomas.
    Boehling NS; Grosshans DR; Bluett JB; Palmer MT; Song X; Amos RA; Sahoo N; Meyer JJ; Mahajan A; Woo SY
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):643-52. PubMed ID: 21277111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative treatment planning on localized prostate carcinoma conformal photon- versus proton-based radiotherapy.
    Mock U; Bogner J; Georg D; Auberger T; Pötter R
    Strahlenther Onkol; 2005 Jul; 181(7):448-55. PubMed ID: 15995838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integral dose in three-dimensional conformal radiotherapy, intensity-modulated radiotherapy and helical tomotherapy.
    Yang R; Xu S; Jiang W; Xie C; Wang J
    Clin Oncol (R Coll Radiol); 2009 Nov; 21(9):706-12. PubMed ID: 19713087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reducing the risk of xerostomia and mandibular osteoradionecrosis: the potential benefits of intensity modulated radiotherapy in advanced oral cavity carcinoma.
    Ahmed M; Hansen VN; Harrington KJ; Nutting CM
    Med Dosim; 2009; 34(3):217-24. PubMed ID: 19647632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of radiotherapy for 230 patients with stage I-II seminomas.
    Hültenschmidt B; Budach V; Genters K; Sack H
    Strahlenther Onkol; 1996 Apr; 172(4):186-92. PubMed ID: 8623080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow-sparing intensity-modulated radiation therapy for Stage I seminoma.
    Zilli T; Boudreau C; Doucet R; Alizadeh M; Lambert C; van Nguyen T; Taussky D
    Acta Oncol; 2011 May; 50(4):555-62. PubMed ID: 21413852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect on esophagus after different radiotherapy techniques for early stage Hodgkin's lymphoma.
    Jørgensen AY; Maraldo MV; Brodin NP; Aznar MC; Vogelius IR; Rosenschöld PM; Petersen PM; Specht L
    Acta Oncol; 2013 Oct; 52(7):1559-65. PubMed ID: 24047340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.